Lonza is building the technological basis of its nutrition business
with the acquisition of assets from Canada's SAM Electron
Technologies, plus the license for innovative and ecological
vitamin K production technology.
Swiss chemicals group Lonza has announced a strategic investment of
$200m in its operations in China, with the investment boosting all
the business including its rapidly expanding nutrition business
portfolio.
Swiss fine chemicals group Lonza said yesterday that it saw strong
demand for its nutrition products during the first half but high
raw material and energy costs continued to erode margins, writes
Dominique Patton.